{"id":"https://openalex.org/W2107355697","doi":"https://doi.org/10.1136/annrheumdis-2012-202221","title":"Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial","display_name":"Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial","publication_year":2012,"publication_date":"2012-11-18","ids":{"openalex":"https://openalex.org/W2107355697","doi":"https://doi.org/10.1136/annrheumdis-2012-202221","mag":"2107355697","pmid":"https://pubmed.ncbi.nlm.nih.gov/23161899"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2012-202221","doi":"https://doi.org/10.1136/annrheumdis-2012-202221","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2012-202221","pdf_url":"https://ard.bmj.com/content/annrheumdis/72/5/741.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/72/5/741.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006123817","display_name":"Ren\u00e9 Westhovens","orcid":"https://orcid.org/0000-0002-3432-3073","observed_orcids":["https://orcid.org/0000-0002-3432-3073"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Ren\u00e9 Westhovens","raw_affiliation_strings":["Department of Rheumatology, University Hospital KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, University Hospital KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069497341","display_name":"Filip De Keyser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801227569","display_name":"Ghent University Hospital","ror":"https://ror.org/00xmkp704","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801227569"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Filip De Keyser","raw_affiliation_strings":["Department of Rheumatology, Ghent University Hospital, Ghent, Belgium","Dept of Rheumatology, Ghent University Hospital, Ghent, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Ghent University Hospital, Ghent, Belgium","institution_ids":["https://openalex.org/I2801227569"]},{"raw_affiliation_string":"Dept of Rheumatology, Ghent University Hospital, Ghent, Belgium","institution_ids":["https://openalex.org/I2801227569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028916428","display_name":"\u0414. \u0413. \u0420\u0435\u043a\u0430\u043b\u043e\u0432","orcid":"https://orcid.org/0000-0002-5793-2322","observed_orcids":["https://orcid.org/0000-0002-5793-2322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dmytro Rekalov","raw_affiliation_strings":["Department of Rheumatology, Zaporizhzhia Regional Hospital, Zaporozhe, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Zaporizhzhia Regional Hospital, Zaporozhe, Ukraine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022097092","display_name":"Evgeny Lvovich Nasonov","orcid":"https://orcid.org/0000-0002-1598-8360","observed_orcids":["https://orcid.org/0000-0002-1598-8360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evgeny L Nasonov","raw_affiliation_strings":["Department of Rheumatology, Institute of Rheumatology, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Institute of Rheumatology, Moscow, Russia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013669018","display_name":"Johan R. Beetens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85459889","display_name":"Galapagos (Belgium)","ror":"https://ror.org/04e4j5d46","country_code":"BE","type":"company","lineage":["https://openalex.org/I85459889"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Johan Beetens","raw_affiliation_strings":["Clinical Development Department, Gal\u00e1pagos NV, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Gal\u00e1pagos NV, Mechelen, Belgium","institution_ids":["https://openalex.org/I85459889"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101525167","display_name":"Annegret Van der Aa","orcid":"https://orcid.org/0000-0001-9095-8164","observed_orcids":["https://orcid.org/0000-0001-9095-8164"]},"institutions":[{"id":"https://openalex.org/I85459889","display_name":"Galapagos (Belgium)","ror":"https://ror.org/04e4j5d46","country_code":"BE","type":"company","lineage":["https://openalex.org/I85459889"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Annegret Van der Aa","raw_affiliation_strings":["Clinical Development Department, Gal\u00e1pagos NV, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Gal\u00e1pagos NV, Mechelen, Belgium","institution_ids":["https://openalex.org/I85459889"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052273030","display_name":"Piet B. T. P. Wigerinck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85459889","display_name":"Galapagos (Belgium)","ror":"https://ror.org/04e4j5d46","country_code":"BE","type":"company","lineage":["https://openalex.org/I85459889"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Piet Wigerinck","raw_affiliation_strings":["Clinical Development Department, Gal\u00e1pagos NV, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Gal\u00e1pagos NV, Mechelen, Belgium","institution_ids":["https://openalex.org/I85459889"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058667154","display_name":"Florence Namour","orcid":"https://orcid.org/0000-0002-8273-5451","observed_orcids":["https://orcid.org/0000-0002-8273-5451"]},"institutions":[{"id":"https://openalex.org/I4210112084","display_name":"Galapagos (France)","ror":"https://ror.org/023bt3h76","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210112084","https://openalex.org/I85459889"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Namour","raw_affiliation_strings":["Clinical Development Department, Gal\u00e1pagos SASU, Romainville, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Gal\u00e1pagos SASU, Romainville, France","institution_ids":["https://openalex.org/I4210112084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111875619","display_name":"Fr\u00e9d\u00e9ric P. Vanhoutte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85459889","display_name":"Galapagos (Belgium)","ror":"https://ror.org/04e4j5d46","country_code":"BE","type":"company","lineage":["https://openalex.org/I85459889"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Fr\u00e9d\u00e9ric Vanhoutte","raw_affiliation_strings":["Clinical Development Department, Gal\u00e1pagos NV, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Gal\u00e1pagos NV, Mechelen, Belgium","institution_ids":["https://openalex.org/I85459889"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083576726","display_name":"Patrick Durez","orcid":"https://orcid.org/0000-0002-7156-2356","observed_orcids":["https://orcid.org/0000-0002-7156-2356"]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Patrick Durez","raw_affiliation_strings":["Department of Rheumatology, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Universit\u00e9 Catholique de Louvain, Brussels, Belgium","institution_ids":["https://openalex.org/I95674353"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5111875619"],"corresponding_institution_ids":["https://openalex.org/I85459889"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":1.4687,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.81741169,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"72","issue":"5","first_page":"741","last_page":"744"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/methotrexate-refractory-rheumatoid-arthritis","display_name":"methotrexate-refractory rheumatoid arthritis","score":0.9039999842643738},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7319999933242798},{"id":"https://openalex.org/keywords/acr20-response","display_name":"ACR20 response","score":0.8730000257492065},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.5960000157356262},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.6269999742507935},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7960000038146973},{"id":"https://openalex.org/keywords/dose-finding","display_name":"dose-finding","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.929040253162384},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7875750064849854},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7404440641403198},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.6892134547233582},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.6627002954483032},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6174353361129761},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6116141676902771},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5287864804267883},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.47574636340141296},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4380946457386017},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4308880865573883},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.39083045721054077},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35556358098983765},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.16983437538146973},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07619941234588623},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06679213047027588}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D047908","descriptor_name":"Intracellular Signaling Peptides and Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D047908","descriptor_name":"Intracellular Signaling Peptides and Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1136/annrheumdis-2012-202221","doi":"https://doi.org/10.1136/annrheumdis-2012-202221","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2012-202221","pdf_url":"https://ard.bmj.com/content/annrheumdis/72/5/741.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmid:23161899","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23161899","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:archive.ugent.be:4207257","doi":null,"is_oa":true,"landing_page_url":"https://biblio.ugent.be/publication/4207257","pdf_url":"https://biblio.ugent.be/publication/4207257/file/4208222.pdf","source":{"id":"https://openalex.org/S4306400478","display_name":"Ghent University Academic Bibliography (Ghent University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32597200","host_organization_name":"Ghent University","host_organization_lineage":["https://openalex.org/I32597200"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 0003-4967","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:124332","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/124332","pdf_url":null,"source":{"id":"https://openalex.org/S4306401974","display_name":"DIAL (Catholic University of Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the rheumatic diseases, (2012)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:156746","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/156746","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the Rheumatic Diseases, Vol. 72, no.5, p. 741-744 (2012)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:open-archive.highwire.org:annrheumdis:annrheumdis-2012-202221v1","doi":null,"is_oa":false,"landing_page_url":"http://ard.bmj.com/cgi/content/short/annrheumdis-2012-202221v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2012-202221","doi":"https://doi.org/10.1136/annrheumdis-2012-202221","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2012-202221","pdf_url":"https://ard.bmj.com/content/annrheumdis/72/5/741.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2107355697.pdf","grobid_xml":"https://content.openalex.org/works/W2107355697.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W41924031","https://openalex.org/W1978576762","https://openalex.org/W2037576960","https://openalex.org/W2062697678","https://openalex.org/W2074438676","https://openalex.org/W2088158803","https://openalex.org/W2110826367","https://openalex.org/W2125076610","https://openalex.org/W2149026148","https://openalex.org/W4311675917"],"related_works":["https://openalex.org/W4250269863","https://openalex.org/W2300875479","https://openalex.org/W3093966040","https://openalex.org/W2551245731","https://openalex.org/W1977683934","https://openalex.org/W2101217991","https://openalex.org/W2068330850","https://openalex.org/W4313648291","https://openalex.org/W2054828913","https://openalex.org/W2006499987"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}